Primus In News
Indian pharma ramps up US acquisitions amid regulatory and market shifts
15-03-2025
Nilaya Varma, CEO & Co-Founder, Primus Partners, and Vivek Tandon, Vice President, Primus Partners, share their view on the expansion of Indian pharmaceutical companies in the US through strategic acquisitions. They highlight Sun Pharma’s $355 million acquisition of Checkpoint Therapeutics as a key move to bolster its oncology and immunotherapy portfolio.
Explore Related Insights
- Institute for Competitiveness and Primus Partners launch their Dialogue Series on Digital India Act
- Delegation discusses setting up of Donkey Conservation Park with LG
- Three-wheeler market may keep chugging in FY26 with 6-8% sales growth
- JioHotstar taps influencers to turn Wimbledon into a lifestyle experience for India’s young consumers